Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1472-6.
Gold Philip J, Goldman Bryan, Iqbal Syma, Leichman Lawrence P, Zhang Wu, Lenz Heinz-Josef, Blanke Charles
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: